• About us
• Contact

Advertisement

Product › Details

CHO.Right® development and manufacturing platform

	Next higher product group	biopharmaceutical production technology_o
	Status	2018-04-18 sales existent
	Organisation	ProBioGen AG
	Group	Minapharm (Group)

Record changed: 2026-01-07

Advertisement

More documents for CHO.Right® development and manufacturing platform

• [1] ProBioGen AG. (1/6/26). "Press Release: ProBioGen and Zag Bio Forge Strategic CMC Partnership to Advance Fc-Fusion Autoimmune Therapy". Berlin....
• [2] ProBioGen AG. (12/9/25). "Press Release: ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101". Berlin....
• [3] ProBioGen AG. (5/29/24). "Press Release: ModeX Therapeutics Leverages ProBioGen's Expertise for Accelerated COVID-19 Antibody Development". Berlin....
• [4] ProBioGen AG. (6/22/21). "Press Release: ProBioGen and Lava Therapeutics N.V. Sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific". Berlin & Utrecht....
• [5] ProBioGen AG. (1/14/20). "Press Release: ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule". Berlin & Utrecht....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.